How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries

How Do Hospital Pharmacists Approach Substitution of Nanomedicines? Insights from a Qualitative Pilot Study and a Quantitative Market Research Analysis in Five European Countries

We conducted research to assess hospital pharmacists’ familiarity with/interpretation of data requirements for the different regulatory approval frameworks and the impact of this on their approach to substitution in the formulary. The online questionnaire included a small molecule (acetylsalicylic a...

Full description

Bibliographic Details
Main Authors: Natalia Sofia, Stefan Mühlebach, Umberto M. Musazzi, Rani Khatib, José Manuel Martinez Sesmero, Hans-Peter Lipp, Jacqueline Surugue, Tiziana Di Francesco, Beat Flühmann
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pharmaceutics
Subjects:
drug substitution
hospital formulary
hospital pharmacy
hybrid approval pathway
nanomedicines
nanosimilars
Online Access:https://www.mdpi.com/1999-4923/13/7/1010

Internet

https://www.mdpi.com/1999-4923/13/7/1010

Similar Items